• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Rituximab Product Approval Information - Licensing Action

Proper name: Rituximab
Tradename: Rituxan
Manufacturer: Genentech, Inc, South San Francisco, CA, License #1048
Indication for Use: Treatment of patients with relapsed or refractory low-grade or follicular, B-cell non-Hodgkin's lymphoma
Approval Date: 11/26/97
Type of submission: Biologics license application


Approval Letter - PDF

Label - PDF

Reviews (PDF)
    page number 20 posted 9/9/98]
    Product (9 pages)